Another fine Irishman...(sarcasm) Daniel O'Day, the current CEO and COB of Gilead Sciences (2019) and former CEO of Roche Pharmaceuticals...(pay raise)...suggests that Gileads appetite for deals... is in the "mid-single-digits-Billions"...

How about dessert... Danny boy?